Published in

Wiley, British Journal of Haematology, 4(185), p. 670-678, 2019

DOI: 10.1111/bjh.15814

Links

Tools

Export citation

Search in Google Scholar

Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma

Journal article published in 2019 by Tamer Khashab, Fredrick Hagemeister, Jorge E. Romaguera ORCID, Michelle A. Fanale, Barbara Pro, Peter McLaughlin, M. Alma Rodriguez, Sattva S. Neelapu, Luis Fayad, Anas Younes, Lei Feng, Francisco Vega ORCID, Larry W. Kwak, Felipe Samaniego ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO